In support of our conclusion that CtBP represses the drug resistance of ovarian cancer cells, the pair-wise comparison between cisplatin-resistant and cisplatin-sensitive A2780 cancer cells disclosed that cisplatin-resistant cells significantly downregulated both CtBP1 and CtBP2 (Fig. 4E). This evidence concerns the gene CTBP1 and ovarian carcinoma.